Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 38

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 4
Chunk 38
---
 future events or otherwise, except as may be required by law.

EXECUTIVE OVERVIEW

The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental, and related products and services. For further information on our business and strategy, see Part I, Item 1 - "Business" in our 2024 Form 10-K. 

Financial Highlights

Consolidated Results of Operations (GAAP basis)Three Months Ended September 30,Nine Months Ended September 30,(Dollars in millions)20252024Change20252024ChangePharmacy revenues$56,054 $48,284 16 %$158,336 $135,421 17 %Premiums9,081 11,436 (21)30,973 34,493 (10)Fees and other revenues4,380 3,889 13 12,412 10,862 14 Net investment income233 85 174 707 696 2 Total revenues69,748 63,694 10 202,428 181,472 12 Pharmacy and other service costs55,530 47,565 17 157,196 133,488 18 Medical costs and other benefit expenses7,842 9,527 (18)26,089 28,482 (8)Selling, general and administrative expenses3,362 3,590 (6)11,008 10,979 — Amortization of acquired intangible assets436 436 — 1,280 1,279 — Total benefits and expenses67,170 61,118 10 195,573 174,228 12 Income from operations2,578 2,576 — 6,855 7,244 (5)Interest expense and other(347)(376)(8)(1,046)(1,073)(3)Gain (loss) on sale of businesses38 (87)N/M79 (106)N/MNet investment gains (losses)26 (921)N/M76 (2,805)N/MIncome before income taxes2,295 1,192 93